Evidence map›Paper›PMID 40276228›Full record

ArticleFrontiers in microbiology2025

The fitness connection of antibiotic resistance.

Miklos Fuzi

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Fluoroquinolone Resistance Patterns in Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  5. Review
  6. A spotlight on multidrug-resistantFrontiers in microbiology · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Integrated virulence-resistance profiling ofFrontiers in cellular and infection microbiology · 2026
    Article
  12. Article
  13. Transfer and Fitness of ISMicroorganisms · 2025
    Article
  14. Detection of the ST111 Global High-RiskCurrent issues in molecular biology · 2025
    Article
  15. Frontiers in veterinary science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Miklos FuziIndependent Researcher, Seattle, WA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

More than three decades ago multidrug-resistant (MDR) clones of the pathogens:

Indexed as

clonesenergy saving schemesfitnessfluoroquinolonesresistance

Identifiers

PMID40276228
PMCPMC12020126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.